For the quarter ended September 2025, Natera (NTRA) reported revenue of $592.18 million, up 34.7% over the same period last year. EPS came in at -$0.64, compared to -$0.26 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $511.52 million, representing a surprise of +15.77%. The company delivered an EPS surprise of -64.1%, with the consensus EPS estimate being -$0.39.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Natera performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Tests Processed Volume: 893,600 versus the three-analyst average estimate of 860,882.
- Revenues- Product: $590.2 million versus the four-analyst average estimate of $504.42 million. The reported number represents a year-over-year change of +35.3%.
- Revenues- Licensing and other: $1.99 million compared to the $3.19 million average estimate based on four analysts. The reported number represents a change of -45.3% year over year.
View all Key Company Metrics for Natera here>>>
Shares of Natera have returned +16.2% over the past month versus the Zacks S&P 500 composite's +1.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Natera, Inc. (NTRA): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
